$QSAM Biosciences Receives Orphan Drug Designation from FDA for CycloSam® in the Treatment of Osteosarcoma #UnderValued #otcmarkets #nasdaq #investors https://www.otcmarkets.com/stock/QSAM/news/QSAM-Biosciences-Receives-Orphan-Drug-Designation-from-FDA-for-CycloSam-in-the-Treatment-of-Osteosarcoma?id=317010